TITLE

Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc

AUTHOR(S)
Borm, Katharina; Jakobsen, Martin R.; Cashin, Kieran; Flynn, Jacqueline K.; Ellenberg, Paula; Ostergaard, Lars; Lee, Benhur; Churchill, Melissa J.; Roche, Michael; Gorry, Paul R.
PUB. DATE
November 2016
SOURCE
Retrovirology;11/3/2016, Vol. 13, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Entry of human immunodeficiency virus type 1 (HIV-1) into cells involves the interaction of the viral gp120 envelope glycoproteins (Env) with cellular CD4 and a secondary coreceptor, which is typically one of the chemokine receptors CCR5 or CXCR4. CCR5-using (R5) HIV-1 strains that display reduced sensitivity to CCR5 antagonists can use antagonist-bound CCR5 for entry. In this study, we investigated whether naturally occurring gp120 alterations in HIV-1 subtype C (C-HIV) variants exist in antiretroviral therapy (ART)-naïve subjects that may influence their sensitivity to the CCR5 antagonist maraviroc (MVC). Results: Using a longitudinal panel of 244 R5 Envs cloned from 20 ART-naïve subjects with progressive C-HIV infection, we show that 40% of subjects (n = 8) harbored viruses that displayed incomplete inhibition by MVC, as shown by plateau's of reduced maximal percent inhibitions (MPIs). Specifically, when pseudotyped onto luciferase reporter viruses, 16 Envs exhibited MPIs below 98% in NP2-CCR5 cells (range 79.7-97.3%), which were lower still in 293-Affinofile cells that were engineered to express high levels of CCR5 (range 15.8-72.5%). We further show that Envs exhibiting reduced MPIs to MVC utilized MVC-bound CCR5 less efficiently than MVC-free CCR5, which is consistent with the mechanism of resistance to CCR5 antagonists that can occur in patients failing therapy. Mutagenesis studies identified strain-specific mutations in the gp120 V3 loop that contributed to reduced MPIs to MVC. Conclusions: The results of our study suggest that some ART-naïve subjects with C-HIV infection harbor HIV-1 with reduced MPIs to MVC, and demonstrate that the gp120 V3 loop region contributes to this phenotype.
ACCESSION #
120055942

 

Related Articles

  • Efficacy of 1998 Vs 2006 First-Line Antiretroviral Regimens for HIV Infection: An Ordinary Clinics Retrospective Investigation. Parruti, Giustino; Polilli, Ennio; De Socio, Giuseppe Vittorio; Sozio, Federica; Marconi, Patrizia; Soddu, Viviana; Dalessandro, Margherita; Celesia, Benedetto Maurizio; Pellicanò, Giovanni; Madeddu, Giordano; Vecchiet, Jacopo; Masi, Francesco Di; Mazzotta, Elena; Ursini, Tamara; Martinelli, Canio; Vitiello, Paola; Bonfanti, Paolo; Nigro, Luciano; Mura, Maria Stella; Antinori, Andrea // Journal of Antivirals & Antiretrovirals;2012, Vol. 4 Issue 2, p32 

    Purpose: The evidence suggesting increased HAART efficacy over time comes from randomized trials or cohort studies. This retrospective multicenter survey aimed to assess the variation over time in the efficacy and tolerability of first-line HAART regimens in unselected patients treated in...

  • UTILISATION OF THE NATIONAL ANTIRETROVIRAL THERAPY GUIDELINES AMONG HEALTH CARE PROFESSIONALS WORKING IN ABUJA TREATMENT CENTRES, NIGERIA. Zungu, Lindiwe I.; Abu, Ugbede O.; Ogunbanjo, Gboyega A.; Setswe, Geoffrey K. // African Journal of Primary Health Care & Family Medicine;2009, Vol. 1 Issue 1, p88 

    Background: Access to and utilisations of the National Antiretroviral Treatment Guidelines (NATG) are valuable factors for effective programme implementation. The objective of this study was to investigate the accessibility of the NATG and their utilisation by health care professionals from five...

  • The Information–Motivation–Behavioral Skills Model of ART Adherence in a Deep South HIV+ Clinic Sample. Amico, K. Rivet; Barta, William; Konkle-Parker, Deborah J.; Fisher, Jeffrey D.; Cornman, Deborah H.; Shuper, Paul A.; Fisher, William A. // AIDS & Behavior;Feb2009, Vol. 13 Issue 1, p66 

    High levels of adherence to antiretroviral therapy (ART) are critical to the management of HIV, yet many people living with HIV do not achieve these levels. There is a substantial body of literature regarding correlates of adherence to ART, and theory-based multivariate models of ART adherence...

  • An Investigation of the Determinants of Adherence to Highly Active Anti-Retroviral Therapy (HAART) in Aboriginal Men in the Downtown Eastside (DTES) of Vancouver. Chongo, Meck; Lavoie, Josée G.; Hoffman, Ross; Shubair, Mamdouh // Canadian Journal of Aboriginal Community-Based HIV/AIDS Research;Winter2011, Vol. 4, p32 

    The eradication of HIV is not yet possible; therefore persons undergoing treatment must take highly active antiretroviral therapy (HAART) regularly. In British Columbia (BC), antiretrovirals are distributed at no cost but the HIV-related annual mortality rate stands at 9% (Vancouver Native Heath...

  • Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis? van der Kop, Mia L. // Journal of Neurology, Neurosurgery & Psychiatry;Jan2015, Vol. 86 Issue 1, p3 

    The article presents a case study that examines the association of HIV and its treatment with antiretroviral therapy (ART) on multiple sclerosis (MS). Topics discussed include use of data of HIV patients between 1999 and 2011 followed up with records of MS, authors of the study showing that the...

  • The future of antiretroviral therapy: challenges and needs. Moreno, Santiago; López Aldeguer, Jose; Arribas, José Ramón; Domingo, Pere; Iribarren, Jose Antonio; Ribera, Esteban; Rivero, Antonio; Pulido, Federico // Journal of Antimicrobial Chemotherapy (JAC);May2010, Vol. 65 Issue 5, p827 

    The introduction of combination antiretroviral therapy (cART) has substantially modified the natural history of HIV infection. At the beginning of the cART era the objective was focused on HIV-1-associated mortality and morbidity, but as this objective was accomplished other issues emerged,...

  • Validation of self-report and hospital pill count using unannounced home pill count as methods for determination of adherence to antiretroviral therapy. MINZI, O. M. S.; NAAZNEEN, A. S. // Tanzania Journal of Health Research;Jun2008, Vol. 10 Issue 2, p84 

    Adherence to anti-retroviral therapy (ART) is very crucial for successful treatment outcomes. This study aimed to validate patient-self report (PSR) and hospital based pill count (HoPC) as adherence determination methods by using unannounced home visit pill count (HPC). The study was carried out...

  • Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo. Kiem, H.-P.; Wu, R. A.; Sun, G.; von Laer, D.; Rossi, J. J.; Trobridge, G. D. // Gene Therapy;Jan2010, Vol. 17 Issue 1, p37 

    Highly active antiretroviral therapy has greatly reduced the morbidity and mortality from human immunodeficiency virus (HIV) infection, but AIDS continues to be a serious health problem worldwide. Despite enormous efforts to develop a vaccine, there is still no cure, and alternative approaches...

  • Targeted Cytotoxic Therapy Kills Persisting HIV Infected Cells During ART. Denton, Paul W.; Long, Julie M.; Wietgrefe, Stephen W.; Sykes, Craig; Spagnuolo, Rae Ann; Snyder, Olivia D.; Perkey, Katherine; Archin, Nancie M.; Choudhary, Shailesh K.; Yang, Kuo; Hudgens, Michael G.; Pastan, Ira; Haase, Ashley T.; Kashuba, Angela D.; Berger, Edward A.; Margolis, David M.; Garcia, J. Victor // PLoS Pathogens;Jan2014, Vol. 10 Issue 1, p1 

    Antiretroviral therapy (ART) can reduce HIV levels in plasma to undetectable levels, but rather little is known about the effects of ART outside of the peripheral blood regarding persistent virus production in tissue reservoirs. Understanding the dynamics of ART-induced reductions in viral RNA...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics